Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: potential licencees...why are they holding out?
Entirely possible that TPL is reluctant to sign for chump change. Not negotiating at all because they are holding out for the big bucks. I am not quite so sure. It may demonstrate their level of confidence but it is certainly taking a toll on investor confidence. Would not one impressive signing, at this stage, in view of the uncertainties or unresolved issues, that I mentioned, put needed pressure on J3 and restore order to the masses....even if it does nothing for share price.
Share
New Message
Please login to post a reply